Orchard Therapeutics PLC - ADR (ORTX) stock is down -61.37% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ORTX stock a score of 30 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 1. ORTX's rank also includes a long-term technical score of 1. The fundamental score for ORTX is 87. In addition to the average rating from Wall Street analysts, ORTX stock has a mean target price of 15. This means analysts expect the stock to add 208.64% over the next 12 months.
What's Happening with ORTX Stock Today
Orchard Therapeutics PLC - ADR (ORTX) stock has risen 15.71% while the S&P 500 has gained 0.48% as of 10:16 AM on Friday, Oct 16. ORTX has gained $0.66 from the previous closing price of $4.20 on volume of 589,461 shares. Over the past year the S&P 500 has risen 16.75% while ORTX is down -61.37%. ORTX lost -$1.83 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Orchard Therapeutics PLC - ADR (ORTX) Stock.
